Use of Nucleic Acid Tests to Reduce the Risk of Transmission of Hepatitis B Virus from Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products

Nucleic Acid Tests, NAT, Tissue, Donor Eligibility, Hepatitis B Virus, Human Cells, Tissues, and Cellular and Tissue-Based Products, CBER, Biologics

via Whats New Vaccines Blood Biologics RSS Feed http://bit.ly/2VvNaKO